BioMerieux's latest results highlight how pharma quality control, mycoplasma testing and advanced microbiological solutions are becoming important drivers of growth in industrial diagnostics.
Novartis' pelacarsen setback puts Lp(a) screening in India under focus, highlighting inherited cholesterol risks, preventive testing and gaps in cardiovascular risk assessment in Indian healthcare.
Cerus' Phase 3 success advances Blood Safety research, raising questions about pathogen reduction's potential role in strengthening India's blood transfusion infrastructure and preparedness.
Center expands drug import gateways under Rule 43A, aiming to ease pharma logistics, improve cargo movement and reduce clearance delays.
Granules India delivers a robust second-quarter performance in FY27 as net profit climbs 39% to Rs 182 crore while revenue advances 20% to Rs 1,560 crore.
Dr Reddy’s lenacapavir gets USFDA nod for HIV prevention, advancing affordable twice-yearly injections and expanding access across 120 low- and middle-income countries.
Fresenius is expanding its biosimilar manufacturing strategy through a WuXi Biologics partnership, gaining access to 37 candidates and strengthening its long-term biopharma ambitions.
Patan's new cancer hospital adds Rs 22 crore radiotherapy capacity and free PET scans for eligible beneficiaries, raising hopes of better regional cancer care access.
RPG Life Sciences' 500 crore acquisition bet could redefine its API business, expand manufacturing capacity and accelerate export growth.
Haryana's Private Healthcare Integration challenge highlights the gap between public healthcare mapping and private-sector participation in India's expanding digital health infrastructure.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
